• 

  Is a Cellular ‘Stalled Engine’ Causing Alzheimer’s?
• 

  Stem Cells for Alzheimer’s? Neurologists Weigh In on Longeveron’s New Data
• 

  Everything You Wanted to Know About ARIA
• 

  Precision Prevention: The Latest on Alzheimer’s Vaccines
• 

  A Stem Cell Therapy for Parkinson’s Disease Heads to Phase 3 Trials
• 

  How Down Syndrome Research Is Helping Scientists Understand Alzheimer’s
• 

  EU Approves Leqembi: Regulators Flip from ‘No’ to ‘Yes’ on Alzheimer’s Drug
• 

  Alzheimer’s Drug Trials: Do Drug Companies Warn You About Your Genetic Risk?
• 

  Trojan Horse: Carrying Alzheimer’s Antibodies Into the Brain
• 

  It Takes Tau to Tangle: Is Faster Buildup Driving Women’s Alzheimer’s Risk?
• 

  In Trials: A Powerful Magnet for Zapping Alzheimer’s Away
• 

  States Propose Bills to Make Private Insurers Cover Approved Alzheimer’s Drugs, Diagnostics
• 

  What Can We Learn About Dementia from LGBTQ+ Brain Health Research?
• 

  Alzheon Alzheimer’s Pill Misses the Mark in Phase 3 Trial, Hints at Benefit in MCI
• 

  After Two Phase 3 Trial Fails, Cassava Sciences Gives Up On Alzheimer’s Drugs

Previous789Next